In summary, the brainstem manifestations either as transient deficits, i.e., “brainstem attacks” or as oculomotor dysfunction are among the most notable preceding symptoms in patients with ataxia associated with high-titer and low-titer anti-GAD Abs. This evidence concerns the gene GAD1 and cerebellar ataxia.